Maryland establishes Emergency Use Epinephrine Program for eligible institutions

March 10, 2025 | House Bills (Introduced), 2025 Bills, Maryland Legislation Bills Collections, Maryland


This article was created by AI summarizing key points discussed. AI makes mistakes, so for full details and context, please refer to the video of the full meeting. Please report any errors so we can fix them. Report an error »

Maryland establishes Emergency Use Epinephrine Program for eligible institutions
On March 10, 2025, Maryland lawmakers introduced House Bill 420, a significant legislative measure aimed at enhancing emergency medical response capabilities within higher education institutions. The bill establishes an Emergency Use Epinephrine Program, designed to authorize specific facilities—namely food service and recreation and wellness centers at eligible institutions—to obtain, store, and administer emergency epinephrine to individuals experiencing anaphylaxis when immediate medical assistance is unavailable.

The primary objective of House Bill 420 is to address the growing concern over anaphylactic reactions, which can be life-threatening and require swift intervention. By allowing trained personnel at participating facilities to administer epinephrine, the bill seeks to improve safety for students and staff, particularly in environments where food allergies may pose a risk. The legislation defines "eligible institutions" as those with food service or recreation facilities that meet specific criteria, ensuring that the program is implemented in locations where the risk of anaphylaxis is most pertinent.

Key provisions of the bill include the requirement for participating facilities to obtain a prescription for emergency epinephrine from a licensed physician and to store the medication in compliance with manufacturer guidelines. This structured approach aims to ensure that the epinephrine is readily accessible during emergencies, thereby potentially saving lives.

While the bill has garnered support for its proactive stance on public health, it has also sparked debates regarding the training and preparedness of staff to administer the medication. Critics have raised concerns about the adequacy of training programs and the potential liability issues that may arise from administering medical interventions in non-clinical settings. Proponents argue that the benefits of having immediate access to life-saving medication far outweigh the risks, emphasizing the importance of preparedness in educational environments.

The implications of House Bill 420 extend beyond immediate health concerns; they touch on broader social issues related to food allergies and public health awareness. As the prevalence of food allergies continues to rise, the bill reflects a growing recognition of the need for institutions to adapt to these challenges. Experts suggest that successful implementation of the program could serve as a model for other states, potentially leading to nationwide changes in how educational institutions manage health risks associated with food allergies.

As the legislative process unfolds, stakeholders will be closely monitoring discussions around training requirements and liability protections. The outcome of House Bill 420 could set a precedent for how emergency medical responses are handled in educational settings, highlighting the critical intersection of health policy and community safety.

View Bill

This article is based on a bill currently being presented in the state government—explore the full text of the bill for a deeper understanding and compare it to the constitution

View Bill

Sponsors

Proudly supported by sponsors who keep Maryland articles free in 2025

Scribe from Workplace AI
Scribe from Workplace AI